DexCom
DXCM
#877
Rank
HK$222.73 B
Marketcap
HK$571.09
Share price
1.12%
Change (1 day)
-17.21%
Change (1 year)

Revenue for DexCom (DXCM)

Revenue in 2024: HK$31.31 Billion

According to DexCom's latest financial reports the company's current revenue (TTM ) is HK$35.28 Billion. In 2024 the company made a revenue of HK$31.31 Billion an increase over the revenue in the year 2023 that were of HK$28.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DexCom from 2006 to 2024

Annual revenue

Year Revenue Change
2024HK$31.31 B10.67%
2023HK$28.29 B24.44%
2022HK$22.73 B19.08%
2021HK$19.09 B27.83%
2020HK$14.93 B29.93%
2019HK$11.49 B42.3%
2018HK$8.07 B43.91%
2017HK$5.61 B26.27%
2016HK$4.44 B42.68%
2015HK$3.11 B54.98%
2014HK$2.01 B62.04%
2013HK$1.24 B60.28%
2012HK$0.77 B30.68%
2011HK$0.59 B56.52%
2010HK$0.37 B64.38%
2009HK$0.23 B202.87%
2008HK$76.01 M110.7%
2007HK$36.07 M113.79%
2006HK$16.87 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
HK$720.10 B 1,940.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$342.61 B 870.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$271.61 B 669.68%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
HK$170.67 B 383.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
HK$45.97 B 30.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
HK$7.86 B-77.70%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
HK$21.21 B-39.89%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
HK$23.58 B-33.17%๐Ÿ‡บ๐Ÿ‡ธ USA